Acne & Rosacea

UNION therapeutics’ Orismilast is a high potency, next-generation PDE4 inhibitor with broad anti-inflammatory properties also in development for oral treatment of atopic dermatitis (AD) and psoriasis.

Oral orismilast is showing promise in adult with hidradenitis suppurativa (HS), according to positive topline results from the OSIRIS investigator-initiated proof-of-concept study.

UNION therapeutics...

Winlevi (clascoterone cream 1%) will be available in Canada this Fall.  Winlevi (clascoterone cream 1%) will be available in Canada this Fall. 

Health Canada has given its nod to Sun Pharma’s Winlevi (clascoterone cream 1%). 

Winlevi an androgen receptor inhibitor indicated for the topical treatment of acne vulgaris in patients 12 years of a...

Minocycline hydrochloride extended-release tablets are used to treat moderate to severe acne in people 12 years and older.

The U.S. Food and Drug Administration (FDA) has given its nod to Zydus Lifesciences’ generic antibiotic minocycline hydrochloride extended-release tablets for the treatment of moderate to severe acne ...

DFD-29 is being developed for the treatment of papulopustular rosacea by Journey Medical Corporation with Dr. Reddy’s Laboratories Ltd.

DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) doesn’t disrupt the microbial floral in healthy adults with papulopustular rosacea, according to data from a Phase 1 clinical trial.

Cutera’s AviClear initially received FDA clearance for treating acne in March 2022.

The U.S. Food and Drug Administration (FDA) has cleared AviClear as a long-term treatment for mild to severe inflammatory acne vulgaris. 

Cutera’s AviClear initially received FDA clearance for treati...

The $7.5 million expansion project in Johnson City, Tenn. increases manufacturing and warehouse space to support business growth.

Crown Laboratories completed a 60,000-square-foot expansion at its manufacturing complex in Johnson City, Tennessee.

A year in the making, the $7.5 million expansion project at Lafe Cox Drive increas...

The series, which will premiere during the 2023 Tribeca Festival in New York, is part of the "Shine a Light on HS" campaign, which was developed by Novartis to help educate and provide helpful tools to people who are undiagnosed but suffering from the symptoms of HS. 

Novartis is launching a new docuseries, "The Beacons: Illuminating HS Stories, in recognition of Hidradenitis Suppurativa (HS) Awareness Week.

The series, which will premiere during the 2023 Tribeca ...

Images and assets will help dermatologists, NPs and PAs in their practices, and others to share #acnefacts.

The American Acne and Rosacea Society (AARS) has launched a social media toolkit to help dermatology medical professionals who are their members share #acnefacts in recognition of Acne Awareness Month...

Women taking spironolactone saw a significant improvement in their acne after 12 and 24 weeks compared to those taking placebo.

Spironolactone could be a cheap and readily available alternative to antibiotics for women with persistent acne, according to research out of the University of Southampton.

The results of the trial a...

IDP-126 is a combination of an antibiotic, an antibacterial and a retinoid.

The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Ortho Dermatologics’ investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel. T...

The company's latest packaging includes at least 50% postconsumer recycled plastic, plastic alternatives such as aluminum and glass, refillable bottles, and sustainably sourced paperboard.  

Rodan + Fields, LLC. is joining 80 leading companies to support The Recycling Partnership, a nonprofit organization committed to building a better recycling system. 

Investing in The Recycling Partne...

Applications for AARS Clinical Research Awards or the AARS Research Scholar Award are due April 28, 2023

The American Acne and Rosacea Society is extending the deadline to apply for an AARS Clinical Research Award ($10K) or the AARS Research Scholar Award ($75K). 

The new application deadline is Friday,...